Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

GreenBox POS (NASDAQ: GBOX) Is ‘One to Watch’

GreenBox POS reported $8 million in revenue for Q3 2021 on $540 million processed transaction volume GreenBox’s guidance for FY2022 forecasts processing volume of at least $4.9 billion The company’s planned spinoff of its coyni smart contract token technology is expected to accelerate revenue growth GreenBox shareholders will have an opportunity to benefit from dividends […]

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO – the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC” It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the […]

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Signs LOI with Maya to Co-Develop a Prescription Digital Therapeutics Platform Targeting a Trifecta Approach to Patient Care

Mydecine has signed a letter of intent with Maya detailing a collaborative partnership to develop a novel digital therapeutics (“DTx”) platform The DTx platform is expected to create a three-pronged approach to patient care by combining Mydecine’s Mindleap digital health platform with its medication-based treatments According to COO Damon Michaels, the new platform will provide […]

Mullen Automotive Inc. (NASDAQ: MULN) Receives Rave Reviews Following Debut at LA Auto Show; Mullen FIVE RS Aims to Be World’s Fastest EV

Mullen Automotive launched the Mullen FIVE EV Crossover at the recent LA Auto Show, with the vehicle winning the auto show’s ZEVA(R) award for top all-electric SUV The Mullen FIVE has seen a spike in popularity following its debut, with the carmaker recently opting to lift the initial reservation limit to 25,000 vehicles The future […]

InnerScope Hearing Technologies Inc. (INND) Completes Key Acquisitions as Hearing Aid Market Poised for DTC Transition in 2022

The World Health Organization estimates by 2050 nearly 2.5 billion people will have some degree of hearing loss and at least 700 million will require hearing rehabilitation InnerScope Hearing Technologies has made transformational moves in 2021 to position itself as a leader in direct-to-consumer (“DTC”) sales of hearing aids and related products InnerScope recently acquired […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”) CEO notes that CYB003 has the potential to achieve better patient outcomes The coming year holds significant promise for Cybin […]

Friendable Inc.’s (FDBL) Fan Pass Live Platform Announces January Contest on Instagram; Winter Merchandise Collection Available in Dedicated Online Shop

Besides the monthly contest prizes, artists who promote three of their streams on Instagram and tag @fanpasslive have the opportunity to earn an additional $30 this month Fan Pass Live’s Winter Merchandise Collection is now available for purchase on the website – the merchandise is Fan Pass branded and features items like hoodies, socks, beanies, […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.